4BIO Capital is a Geneva-based biotech-focused venture capital firm specializing in advanced therapeutics — gene therapy, cell therapy, and gene editing. The firm invests in next-generation medicines with transformative potential, targeting seed to Series A.
The scientific team brings deep biotechnology expertise, and the firm is active in both European and US biotech ecosystems. Partnerships wit...
London, United Kingdom
Melbourne, Australia
Leverkusen, Germany
Amsterdam, Netherlands
Basel, Switzerland
Boston, United States